APOP - セレクト・バイオテクノロジ― （Cellect Biotechnology Ltd.） セレクト・バイオテクノロジ―APOPのチャート
APOPの企業情報
| symbol | APOP |
|---|---|
| 会社名 | Cellect Biotechnology Ltd （セレクト・バイオテクノロジ―） |
| 分野（sector） | ― |
| 産業（industry） | ― |
| 業種 | ― 医療関連（Health Care） |
| 概要 | 事業概要 -- セレクト・バイオテクノロジ―はイスラエルのバイオ医薬品企業。主に、免疫細胞治療、幹細胞治療、再生医療の開発に従事する。同社のプラットフォ―ムは幹細胞の特性に基づき、アポト―シス(細胞死)誘導エ―ジェントを開発する。動物実験では成果があり、今後は臨床試験やパイプラインの開発に取り組む。本社はクファ―ルサバ。 Cellect Biotechnology has developed a breakthrough technology, for the selection of stem cells from any given tissue, that aims to improve a variety of stem cell-based therapies. |
| 本社所在地 | 23 Ha'Taas St. Kfar Saba ISR |
| 代表者氏名 | ― |
| 代表者役職名 | ― |
| 電話番号 | ― |
| 設立年月日 | － |
| 市場名 | NASDAQ Small Cap |
| ipoyear | 2016年 |
| 従業員数 | － |
| url | www.cellectbio.com |
| nasdaq_url | https://www.nasdaq.com/symbol/apop |
| adr_tso | 6468992 |
| EBITDA | EBITDA ー |
| 終値（lastsale） | 4.8073 |
| 時価総額（marketcap） | 31098385.2416 |
| 時価総額 | 時価総額 ― |
| 売上高 | 売上高 -- |
| 企業価値(EV) | 企業価値(EV) ー |
| 当期純利益 | 当期純利益 -- |
| 決算概要 | 決算概要 -- |
APOPのテクニカル分析
APOPのニュース
Definitive Proof this stocks will never make you disappointed: FuelCell Energy, Inc. (NASDAQ:FCEL -9.62%), Cellect Biotechnology Ltd. (NASDAQ:APOP -9.30%) 2021/10/22 23:50:38 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Definitive Proof this stocks will never make you disappointed: FuelCell Energy, Inc. (NASDAQ:FCEL -9.62%), Cellect Biotechnology Ltd. (NASDAQ:APOP -9.30%) appeared first on Stocks Equity .
Shareholders are distrustful How to React (Brief breakdown): Cellect Biotechnology Ltd. (NASDAQ:APOP 16.03%), ConocoPhillips (NYSE:COP 2.24%) 2021/09/27 23:35:40 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Shareholders are distrustful How to React (Brief breakdown): Cellect Biotechnology Ltd. (NASDAQ:APOP 16.03%), ConocoPhillips (NYSE:COP 2.24%) appeared first on Stocks Equity .
Cellect Bio jumps 49% on shareholder approval for Quoin Pharma merger 2021/09/27 13:24:29 Seeking Alpha
Cellect Biotechnology Announces Shareholder Approval of Strategic Merger with Quoin Pharmaceuticals 2021/09/27 13:10:00 Intrado Digital Media
Tel Aviv, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), announced shareholders voted to approve the previously announced strategic merger agreement with privately-held Quoin Pharmaceuticals, a specialty pharmaceutical company focused on rare and orphan diseases, and all other proposals presented at the Special General Meeting of shareholders held on September 26, 2021, including the sale of the Companys subsidiary, Cellect Biotherapeutics Ltd, to EnCellX Inc. , a privately held company based in San Diego, CA.
Midday Meme Stock Report for 9/24: Camber Energy, Canoo, Cellect Bio, Naked Brands 2021/09/24 17:24:28 24/7 Wall street
The Buzz Show: Cellect Biotechnology Ltd. (NASDAQ: APOP) ApoGraft Transplantation in U.S. Patient 2021/09/03 23:36:54 Financial Buzz
FinancialBuzz.coms latest The Buzz Show: Featuring Our Corporate News Recap on Cellect Biotechnology Ltd. Announces First ApoGraft Transplantation in U.S. Patient Cellect Biotechnology Ltd. (NASDAQ: APOP) surged over 61% in premarket trading after the company announced the first ApoGraft transplantation in a Leukemia patient in the Companys clinical trial at Washington University in the The post The Buzz Show: Cellect Biotechnology Ltd. (NASDAQ: APOP) ApoGraft Transplantation in U.S. Patient first appeared on Financial Buzz .
Thinking about buying stock in Meta Materials, Cellect Biotechnology, Forte Biosciences, Camber Energy, or Denison Mines? 2021/09/03 15:10:00 Benzinga
NEW YORK , Sept. 3, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MMAT, APOP, FBRX, CEI, and DNN. Full story available on Benzinga.com
Enveric Biosciences and Cellect Biotechnology among healthcare gainers; Forte Biosciences among losers 2021/09/03 14:55:58 Seeking Alpha
12 Health Care Stocks Moving In Friday''s Pre-Market Session 2021/09/03 12:16:09 Benzinga
Gainers Cellect Biotechnology (NASDAQ: APOP ) shares rose 68.9% to $9.29 during Friday''s pre-market session. The company''s market cap stands at $36.4 million. Advaxis (NASDAQ: ADXS ) shares increased by 20.49% to $0.56. The market value of their outstanding shares is at $81.3 million. Enveric Biosciences (NASDAQ: ENVB ) shares rose 15.83% to $2.56. The company''s market cap stands at $54.8 million. Soligenix (NASDAQ: SNGX ) shares moved upwards by 8.41% to $1.16. The company''s market cap Full story available on Benzinga.com
20 Stocks Moving in Friday''s Pre-Market Session 2021/09/03 11:01:24 Benzinga
Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP ) rose 59.5% Full story available on Benzinga.com
The Buzz Show: Cellect Biotechnology Ltd. (NASDAQ: APOP) ApoGraft Transplantation in U.S. Patient 2021/09/03 23:36:54 Financial Buzz
FinancialBuzz.coms latest The Buzz Show: Featuring Our Corporate News Recap on Cellect Biotechnology Ltd. Announces First ApoGraft Transplantation in U.S. Patient Cellect Biotechnology Ltd. (NASDAQ: APOP) surged over 61% in premarket trading after the company announced the first ApoGraft transplantation in a Leukemia patient in the Companys clinical trial at Washington University in the The post The Buzz Show: Cellect Biotechnology Ltd. (NASDAQ: APOP) ApoGraft Transplantation in U.S. Patient first appeared on Financial Buzz .
Thinking about buying stock in Meta Materials, Cellect Biotechnology, Forte Biosciences, Camber Energy, or Denison Mines? 2021/09/03 15:10:00 Benzinga
NEW YORK , Sept. 3, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MMAT, APOP, FBRX, CEI, and DNN. Full story available on Benzinga.com
Enveric Biosciences and Cellect Biotechnology among healthcare gainers; Forte Biosciences among losers 2021/09/03 14:55:58 Seeking Alpha
12 Health Care Stocks Moving In Friday''s Pre-Market Session 2021/09/03 12:16:09 Benzinga
Gainers Cellect Biotechnology (NASDAQ: APOP ) shares rose 68.9% to $9.29 during Friday''s pre-market session. The company''s market cap stands at $36.4 million. Advaxis (NASDAQ: ADXS ) shares increased by 20.49% to $0.56. The market value of their outstanding shares is at $81.3 million. Enveric Biosciences (NASDAQ: ENVB ) shares rose 15.83% to $2.56. The company''s market cap stands at $54.8 million. Soligenix (NASDAQ: SNGX ) shares moved upwards by 8.41% to $1.16. The company''s market cap Full story available on Benzinga.com